80.82

0.30% 0.24

Pre-market: 80.73 -0.09 -0.11%

Lemaitre Vascular Inc (LMAT)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Lemaitre Vascular Inc stock is traded at $80.82, with a volume of 320.24K. It is up +0.30% in the last 24 hours and up +1.08% over the past month. LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Previous Close:

$80.58

Open:

$80.64

24h Volume:

320.24K

Relative Volume:

0.92

Market Cap:

$1.85B

Revenue:

$256.28M

Net Income/Loss:

$62.40M

P/E Ratio:

29.78

EPS:

2.7139

Net Cash Flow:

$79.12M

1W Performance:

+1.70%

1M Performance:

+1.08%

6M Performance:

-26.52%

1Y Performance:

-7.95%

1-Day Range:

$79.67

$81.37

1-Week Range:

$78.22

$81.52

52-Week Range:

$78.22

$118.01

Lemaitre Vascular Inc Stock (LMAT) Company Profile

Name

Lemaitre Vascular Inc

Sector

Healthcare (1068)

Industry

Medical Instruments & Supplies (56)

Phone

781-221-2266

Address

63 SECOND AVENUE, BURLINGTON, MA

Employee

655

Twitter

@LMAT_Vascular

Next Earnings Date

2026-11-05

Latest SEC Filings

LMAT's Discussions on Twitter

Compare LMAT vs ISRG, BDX, RMD, ALC, MDLN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LMAT Lemaitre Vascular Inc	80.82	1.85B	256.28M	62.40M	79.12M	2.7139
ISRG Intuitive Surgical Inc	399.52	141.14B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	179.23	48.82B	21.37B	1.41B	3.07B	3.9437
RMD Resmed Inc	221.89	32.01B	5.54B	1.52B	1.74B	10.37
ALC Alcon Inc	64.56	31.21B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	34.66	30.41B	29.14B	1.07B	1.05B	1.1956

Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-06-25	Upgrade	Barrington Research	Mkt Perform → Outperform
Feb-28-25	Downgrade	Barrington Research	Outperform → Mkt Perform
Feb-28-25	Downgrade	Oppenheimer	Outperform → Perform
Feb-13-25	Initiated	Wells Fargo	Equal Weight
Oct-15-24	Initiated	Cantor Fitzgerald	Neutral
Aug-02-24	Resumed	Lake Street	Buy
May-31-24	Resumed	ROTH MKM	Buy
Apr-26-24	Upgrade	Stifel	Hold → Buy
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-23-23	Initiated	JMP Securities	Mkt Outperform
Sep-06-23	Initiated	Oppenheimer	Outperform
Aug-03-23	Downgrade	Jefferies	Buy → Hold
May-03-23	Upgrade	Barrington Research	Mkt Perform → Outperform
Oct-28-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Sep-16-21	Initiated	Jefferies	Buy
Feb-12-21	Initiated	KeyBanc Capital Markets	Sector Weight
Mar-16-20	Upgrade	Sidoti	Neutral → Buy
Oct-24-19	Downgrade	First Analysis Sec	Strong Buy → Outperform
Oct-24-19	Upgrade	Lake Street	Hold → Buy
Oct-14-19	Upgrade	First Analysis Sec	Outperform → Strong Buy
Jul-25-19	Reiterated	Barrington Research	Outperform
Jul-25-19	Upgrade	First Analysis Sec	Neutral → Outperform
Oct-08-18	Upgrade	Barrington Research	Mkt Perform → Outperform
Oct-08-18	Upgrade	ROTH Capital	Neutral → Buy
Jun-08-18	Resumed	ROTH Capital	Buy
Apr-26-18	Downgrade	Stifel	Buy → Hold
Apr-26-18	Upgrade	The Benchmark Company	Hold → Buy
Oct-27-17	Downgrade	First Analysis Sec	Overweight → Equal-Weight
Oct-27-17	Downgrade	The Benchmark Company	Buy → Hold
Jul-10-17	Downgrade	Canaccord Genuity	Buy → Hold
Jul-10-17	Downgrade	The Benchmark Company	Buy → Hold
Mar-21-17	Initiated	First Analysis Sec	Overweight
Feb-22-17	Downgrade	Barrington Research	Outperform → Mkt Perform
Sep-22-16	Downgrade	Sidoti	Buy → Neutral
Jul-28-16	Reiterated	Barrington Research	Outperform
Feb-25-16	Reiterated	Barrington Research	Outperform

View All

Lemaitre Vascular Inc Stock (LMAT) Latest News

Sep 24, 2026

Is LeMaitre Vascular (LMAT) A Bargain Following Its 90 Day Pullback? - finance.yahoo.com

Sep 24, 2026

LeMaitre Vascular (LMAT) Stock Looks Fully Priced On Its 57% Five Year Run - finance.yahoo.com

Sep 23, 2026

LeMaitre Vascular Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Customer Data Is Exposed - PR Newswire

Sep 23, 2026

Sep 22, 2026

LeMaitre Vascular stock holds at USD 79.13 as valuation draws scrutiny - AD HOC NEWS

Sep 22, 2026

Understanding the Setup: (LMAT) and Scalable Risk - news.stocktradersdaily.com

Sep 22, 2026

Sep 21, 2026

LeMaitre Vascular Data Breach Investigation - Claim Depot

Sep 21, 2026

LeMaitre Vascular (NASDAQ:LMAT) Hits New 52-Week LowTime to Sell? - MarketBeat

Sep 21, 2026

LeMaitre Vascular Data Breach Exposes Social Security Numbers - Claim Depot

Sep 21, 2026

LeMaitre Vascular stock hits 52-week low at 78.22 USD By Investing.com - Investing.com India

Sep 21, 2026

LeMaitre Vascular stock hits 52-week low at 78.22 USD - Investing.com

Sep 21, 2026

Sep 20, 2026

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Hold" from Brokerages - MarketBeat

Sep 20, 2026

Sep 17, 2026

LeMaitre Vascular Q2 2026 Earnings: EPS Misses Estimates as Shares SlipPost-Earnings Reaction - careplusvn.com

Sep 17, 2026

Sep 15, 2026